Journal
AMERICAN JOURNAL ON ADDICTIONS
Volume 30, Issue 1, Pages 83-87Publisher
WILEY
DOI: 10.1111/ajad.13069
Keywords
-
Categories
Funding
- National Institute on Drug Abuse, Bethesda, MD [NIDA UG3DA048734]
Ask authors/readers for more resources
This case series described buprenorphine/naloxone inductions of four individuals who tested positive for fentanyl, and indicated that a revised induction strategy could help prevent precipitated withdrawal in individuals exposed to illicit fentanyl.
Background and Objectives Individuals exposed to fentanyl are at risk of precipitated withdrawal using typical buprenorphine/naloxone induction procedures. Methods This case series describes buprenorphine/naloxone inductions of four individuals who tested positive for fentanyl. Results Buprenorphine-precipitated withdrawal was observed in two individuals who completed a conventional buprenorphine/naloxone induction strategy. Two more individuals completed a revised buprenorphine/naloxone induction strategy that did not precipitate withdrawal. Discussion and Conclusion Using multiple 2 mg doses of buprenorphine/naloxone in patients already in mild/moderate withdrawal improved outcomes. Scientific Significance Persons who use illicit fentanyl might be less likely to experience precipitated withdrawal from this revised buprenorphine/naloxone induction strategy. (Am J Addict 2020;00:00-00)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available